Lvnan Yan

2.8k total citations · 1 hit paper
84 papers, 1.9k citations indexed

About

Lvnan Yan is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Lvnan Yan has authored 84 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hepatology, 36 papers in Surgery and 32 papers in Epidemiology. Recurrent topics in Lvnan Yan's work include Hepatocellular Carcinoma Treatment and Prognosis (39 papers), Liver Disease Diagnosis and Treatment (29 papers) and Liver Disease and Transplantation (22 papers). Lvnan Yan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (39 papers), Liver Disease Diagnosis and Treatment (29 papers) and Liver Disease and Transplantation (22 papers). Lvnan Yan collaborates with scholars based in China, United States and United Kingdom. Lvnan Yan's co-authors include Yong Zeng, Hong Wu, Jiwei Huang, Zheyu Cheng, Liang Du, Yinglong Xu, Jinzhou Wang, Tianfu Wen, Mingqing Xu and Wentao Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Lvnan Yan

81 papers receiving 1.9k citations

Hit Papers

A Randomized Trial Comparing Radiofrequency Ablation and ... 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lvnan Yan China 20 1.2k 813 557 453 436 84 1.9k
Kuang‐Liang King Taiwan 24 1.2k 1.0× 661 0.8× 788 1.4× 544 1.2× 342 0.8× 58 2.1k
Ryuichi Kita Japan 25 1.3k 1.0× 923 1.1× 370 0.7× 359 0.8× 237 0.5× 76 1.8k
Chiaki Kagebayashi Japan 7 1.9k 1.5× 1.4k 1.7× 430 0.8× 455 1.0× 363 0.8× 8 2.3k
Chia‐Yang Hsu Taiwan 26 1.8k 1.5× 1.3k 1.6× 606 1.1× 336 0.7× 395 0.9× 67 2.1k
Anne Durnez Belgium 14 731 0.6× 483 0.6× 436 0.8× 346 0.8× 327 0.8× 21 1.8k
Masahiro Takita Japan 26 1.4k 1.1× 745 0.9× 301 0.5× 397 0.9× 411 0.9× 77 2.1k
Shinichi Ohkawa Japan 24 756 0.6× 697 0.9× 631 1.1× 1.2k 2.6× 410 0.9× 96 2.3k
Jane Koh Hong Kong 16 849 0.7× 568 0.7× 236 0.4× 493 1.1× 246 0.6× 31 1.7k
Atsuyuki Maeda Japan 26 787 0.6× 692 0.9× 1.1k 2.0× 974 2.2× 302 0.7× 164 2.3k
Maria Hoppe‐Lotichius Germany 23 1.0k 0.8× 536 0.7× 941 1.7× 464 1.0× 123 0.3× 64 1.8k

Countries citing papers authored by Lvnan Yan

Since Specialization
Citations

This map shows the geographic impact of Lvnan Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lvnan Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lvnan Yan more than expected).

Fields of papers citing papers by Lvnan Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lvnan Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lvnan Yan. The network helps show where Lvnan Yan may publish in the future.

Co-authorship network of co-authors of Lvnan Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Lvnan Yan. A scholar is included among the top collaborators of Lvnan Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lvnan Yan. Lvnan Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Zhenyu, et al.. (2024). A new clinical classification of congenital biliary dilatation – HUAXI CBD classification. BMC Pediatrics. 24(1). 750–750.
2.
Yuan, Jingsheng, Tao Lv, Jian Yang, et al.. (2022). The lipid transporter HDLBP promotes hepatocellular carcinoma metastasis through BRAF-dependent epithelial-mesenchymal transition. Cancer Letters. 549. 215921–215921. 19 indexed citations
3.
Yuan, Jingsheng, Tao Lv, Jian Yang, et al.. (2022). HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma. Redox Biology. 58. 102546–102546. 69 indexed citations
4.
Xu, Liangliang, Lian Li, Peng Wang, et al.. (2019). Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center. Gut and Liver. 13(6). 669–682. 17 indexed citations
5.
Li, Chuan, Chang Liu, Tianfu Wen, et al.. (2019). The outcome of the HCC patients underwent ALPPS. Medicine. 98(38). e17182–e17182. 5 indexed citations
6.
Li, Lei, Haiqing Wang, Jian Yang, et al.. (2018). Geriatric nutritional risk index predicts prognosis after hepatectomy in elderly patients with hepatitis B virus-related hepatocellular carcinoma. Scientific Reports. 8(1). 12561–12561. 44 indexed citations
7.
Shen, Junyi, Chuan Li, Lvnan Yan, et al.. (2017). Short- and Long-term Outcomes between Young and Older HCC Patients Exceeding The Milan Criteria after Hepatectomy. Annals of Hepatology. 17(1). 134–143. 11 indexed citations
8.
Li, Ming, et al.. (2017). Splenectomy before adult liver transplantation: a retrospective study. BMC Surgery. 17(1). 44–44. 3 indexed citations
9.
Shen, Junyi, Chuan Li, Tianfu Wen, et al.. (2016). Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy. Journal of Surgical Research. 209. 102–111. 25 indexed citations
10.
Li, Chuan, Tianfu Wen, Lvnan Yan, et al.. (2016). Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria. Journal of Surgical Research. 209. 8–16. 17 indexed citations
11.
Peng, Wei, Chuan Li, Tianfu Wen, et al.. (2016). Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma. Medicine. 95(30). e4160–e4160. 9 indexed citations
12.
Wen, Tianfu, et al.. (2016). Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study. International Journal of Surgery. 32. 167–173. 15 indexed citations
13.
Liu, Fei, Limei Luo, Yonggang Wei, et al.. (2015). Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population. Gene. 564(1). 14–20. 14 indexed citations
14.
Peng, Wei, Chuan Li, Tian-Fu Wen, et al.. (2014). Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival. Journal of Surgical Research. 192(2). 402–408. 72 indexed citations
15.
Liu, Fei, Limei Luo, Yonggang Wei, et al.. (2012). A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population. Tumor Biology. 34(1). 47–53. 10 indexed citations
16.
Liu, Fei, Yonggang Wei, Limei Luo, et al.. (2012). Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population. Tumor Biology. 34(1). 293–299. 6 indexed citations
17.
Huang, Jiwei, Lvnan Yan, Zheyu Cheng, et al.. (2010). A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria. Annals of Surgery. 252(6). 903–912. 610 indexed citations breakdown →
18.
Dai, Jun & Lvnan Yan. (2009). Long-term prevention of virus recurrence among recipients with HBV active replication following liver transplantation. Zhonghua gan-dan waike zazhi. 15(2). 106–109. 2 indexed citations
19.
Lin, Yi‐Xin, et al.. (2009). Application of bone marrow cells: A novel therapy for bile leak?. Medical Hypotheses. 73(3). 374–376. 4 indexed citations
20.
Liu, Fei, Ya Li, Lan Xiang, et al.. (2009). Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts. World Journal of Gastroenterology. 15(31). 3931–3931. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026